Výsledky vyhledávání - "Masalov, D. V."

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial]

Autor: Krupitskiǐ, E. M., Edwin Zvartau, Tsoǐ-Podosenin, M. V., Masalov, D. V., Burakov, A. M., Egorova, V. I., Didenko, T. I., Romanova, T. N., Ivanova, E. B., Bespalov, A. I., Verbitskaia, E. V., Neznanov, N. G., Grineneko, A. I., O Brien, C., Woody, D.

Publikováno v: Scopus-Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::41a05cd4e7ea552fc43adc427e3e75b4
http://www.scopus.com/inward/record.url?eid=2-s2.0-79953330615&partnerID=MN8TOARS

Zobrazit plný text záznamu

Akademický článek

Prevention of suicide by naltrexone in a recently detoxified heroin addict.

Autor: Krupitsky, E M, Masalov, D V, Didenko, T Y, Burakov, A M, Romanova, T N, Zvartau, E E, Woody, G

Publikováno v: European Addiction Research; 2001, Vol. 7 Issue 3, p87-88, 2p

Zobrazit plný text záznamu

Akademický článek

[Anhedonia, depression, anxiety, and craving in opioid dependent patients stabilized on oral naltrexone or naltrexone implant].

Autor: Krupitsky EM; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia; St. Petersburg Bekhterev Research Psychoneurological Institute, St. Petersburg, Russia; Leningrad Regional Narcology Dispensary, St. Petersburg, Russia; Department of Psychiatry, University of Pennsylvania, Phyladelphia, USA., Zvartau EE; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Blokhina EA; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Verbitskaya EV; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Wahlgren VY; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Tsoy-Podosenin MV; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Bushara NM; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Burakov AM; Leningrad Regional Narcology Dispensary, St. Petersburg, Russia., Masalov DV; Leningrad Regional Narcology Dispensary, St. Petersburg, Russia., Romanova TN; Leningrad Regional Narcology Dispensary, St. Petersburg, Russia., Tiurina AA; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Palatkin VY; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Yaroslavtseva TS; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Sulimov GY; Valdman Institute of Pharmacology of Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia., Pecoraro A; Department of Psychiatry, University of Pennsylvania, Phyladelphia, USA., Woody G; Department of Psychiatry, University of Pennsylvania, Phyladelphia, USA.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2018; Vol. 118 (1. Vyp. 2), pp. 26-33.

Zobrazit plný text záznamu

Akademický článek

[A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].

Autor: Kibitov АО; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Krupitsky ЕМ; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Blokhina ЕА; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Verbitskaya ЕV; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Brodyansky VМ; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Alekseeva NP; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Bushara NМ; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Yaroslavtseva ТS; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Palatkin VY; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Masalov DV; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Burakov АМ; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Romanova ТN; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Sulimov GY; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Grinenko AY; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Kosten Т; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Nielsen D; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia., Zvartau EE; Pavlov First St.Petersburg State Medical University, St.Petersburg, Bekhterev St.Petersburg Research Psychoneurilogical Institute, St.Petersburg, Serbsky Federal Medical research Center for Psychiatry and Narcology, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2016; Vol. 116 (11. Vyp. 2), pp. 36-48.

Zobrazit plný text záznamu

Akademický článek

[Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach].

Autor: Krupitsky ЕМ; Pavlov First St. Petersburg State Medical University, St. Petersburg; Bekhterev St. Petersburg Research Psychoneurological Institute, St. Petersburg., Kibitov АО; National Research Center of Narcology, Moscow., Blokhina ЕА; Pavlov First St. Petersburg State Medical University, St. Petersburg., Verbitskaya ЕV; Pavlov First St. Petersburg State Medical University, St. Petersburg., Brodyansky VМ; National Research Center of Narcology, Moscow., Alekseeva NP; Pavlov First St. Petersburg State Medical University, St. Petersburg., Bushara NМ; Pavlov First St. Petersburg State Medical University, St. Petersburg., Yaroslavtseva ТS; Pavlov First St. Petersburg State Medical University, St. Petersburg., Palatkin VY; Pavlov First St. Petersburg State Medical University, St. Petersburg., Masalov DV; Leningrad Oblast Narcology Dispensary, Leningrad Oblast., Burakov АМ; Leningrad Oblast Narcology Dispensary, Leningrad Oblast., Romanova ТN; Leningrad Oblast Narcology Dispensary, Leningrad Oblast., Sulimov GY; Fidelity Capital, Moscow., Kosten Т; Baylor College of Medicine, Houston, USA., Nielsen D; Baylor College of Medicine, Houston, USA., Zvartau EE; Pavlov First St. Petersburg State Medical University, St. Petersburg., Woody D; Pennsylvanian University, USA.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2015; Vol. 115 (4 Pt 2), pp. 14-23.

Zobrazit plný text záznamu

Akademický článek

[A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].

Autor: Krupitsky EM; Pavlov First St. Petersburg State Medical University, St. Petersburg; Bekhterev St. Petersburg Research Psychoneurological Institute, St. Petersburg., Blokhina EA; Pavlov First St. Petersburg State Medical University, St. Petersburg., Zvartau EE; Pavlov First St. Petersburg State Medical University, St. Petersburg., Verbitskaya VE; Pavlov First St. Petersburg State Medical University, St. Petersburg., Bushara EM; Pavlov First St. Petersburg State Medical University, St. Petersburg., Tiurina AA; Pavlov First St. Petersburg State Medical University, St. Petersburg., Palatkin VY; Pavlov First St. Petersburg State Medical University, St. Petersburg., Yaroslavtseva TS; Pavlov First St. Petersburg State Medical University, St. Petersburg., Burakov AM; Leningrad Obllast Narcological Dispensary, Leningrad oblast., Masalov DV; Leningrad Obllast Narcological Dispensary, Leningrad oblast., Romanova TN; Leningrad Obllast Narcological Dispensary, Leningrad oblast., Grininko AY; Pavlov First St. Petersburg State Medical University, St. Petersburg., Sinha R; Yale University, Department of Psychiatry, New Haven, USA., Kosten T; Beylor College of Medicine, Houston, USA.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2015; Vol. 115 (10), pp. 39-46.

Zobrazit plný text záznamu

Akademický článek

[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].

Autor: Krupitskiĭ EM, Zvartau EE, Tsoĭ-Podosenin MV, Masalov DV, Burakov AM, Egorova VIu, Didenko TIu, Romanova TN, Ivanova EB, Bespalov AIu, Verbitskaia EV, Neznanov NG, Grineneko AIa, O'Brien C, Woody D

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2010; Vol. 110 (5 Pt 2), pp. 44-54.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání